We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+5.25%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$20.4B
AUM Growth
-$79M
Cap. Flow
-$151M
Cap. Flow %
-0.74%
Top 10 Hldgs %
31.15%
Holding
1,305
New
241
Increased
339
Reduced
426
Closed
291

Top Buys

Rank Stock Value
1
ENB icon
Enbridge
ENB
+$166M
2
BNS icon
Scotiabank
BNS
+$139M
3
TD icon
Toronto Dominion Bank
TD
+$129M
4
CVE icon
Cenovus Energy
CVE
+$117M
5
PBA icon
Pembina Pipeline
PBA
+$89.3M

Top Sells

Rank Stock Value
1
CCJ icon
Cameco
CCJ
+$85.9M
2
NVDA icon
NVIDIA
NVDA
+$70.9M
3
CIXX
CI Financial Corp.
CIXX
+$70.7M
4
MSFT icon
Microsoft
MSFT
+$68.2M
5
GRP.U
Granite Real Estate Investment Trust
GRP.U
+$63.1M

Sector Composition

Rank Sector Weight
1 Financials 27.05%
2 Technology 13%
3 Energy 12.62%
4 Industrials 11.87%
5 Materials 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRNO icon
801
Terreno Realty
TRNO
$7.5B
$439K ﹤0.01%
5,927
-14,265
-71% -$1.04M
AZN icon
802
AstraZeneca
AZN
$244B
$438K ﹤0.01%
3,303
-11,462
-78% -$1.37M
BBW icon
803
Build-A-Bear
BBW
$474M
$436K ﹤0.01%
23,829
-9,617
-29% -$182K
RNAC icon
804
Cartesian Therapeutics
RNAC
$264M
$435K ﹤0.01%
11,792
-2,618
-18% -$164K
SPOK icon
805
Spok Holdings
SPOK
$230M
$433K ﹤0.01%
54,311
-10,434
-16% -$94.8K
CVX icon
806
Chevron
CVX
$388B
$432K ﹤0.01%
2,652
-42,049
-94% -$6.03M
ABEV icon
807
Ambev
ABEV
$43.8B
$431K ﹤0.01%
133,558
-465,913
-78% -$1.3M
VZ icon
808
Verizon
VZ
$200B
$430K ﹤0.01%
8,447
-599,900
-99% -$31.8M
NC icon
809
NACCO Industries
NC
$316M
$428K ﹤0.01%
10,909
+1,932
+22% +$63.6K
KDNY
810
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$428K ﹤0.01%
26,147
+5,881
+29% +$80K
ATRA icon
811
Atara Biotherapeutics
ATRA
$76.7M
$426K ﹤0.01%
1,834
+1,095
+148% +$349K
LEGN icon
812
Legend Biotech
LEGN
$3.93B
$417K ﹤0.01%
+11,483
New +$454K
TAL icon
813
TAL Education Group
TAL
$6.43B
$412K ﹤0.01%
136,866
-2,556,559
-95% -$7.85M
AGS
814
DELISTED
PlayAGS
AGS
$411K ﹤0.01%
61,693
-19,004
-24% -$143K
ARQ icon
815
Arq
ARQ
$99.6M
$411K ﹤0.01%
66,094
-1,578
-2% -$10K
GRFS
816
Grifois
GRFS
$5.4B
$410K ﹤0.01%
35,091
-20,972
-37% -$241K
NNBR icon
817
NN Inc
NNBR
$298M
$409K ﹤0.01%
141,884
-9,766
-6% -$32.1K
RMD icon
818
ResMed
RMD
$32.9B
$409K ﹤0.01%
+1,685
New +$408K
GEO icon
819
The GEO Group
GEO
$4B
$406K ﹤0.01%
61,363
-111,869
-65% -$732K
BNED icon
820
Barnes & Noble Education
BNED
$424M
$404K ﹤0.01%
1,130
-727
-39% -$388K
MGNX icon
821
MacroGenics
MGNX
$259M
$400K ﹤0.01%
45,453
+5,657
+14% +$62.4K
VVNT
822
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
$400K ﹤0.01%
59,172
-24,657
-29% -$176K
ADVM
823
DELISTED
Adverum Biotechnologies
ADVM
$397K ﹤0.01%
30,272
-3,602
-11% -$52.7K
PHX
824
DELISTED
PHX Minerals
PHX
$396K ﹤0.01%
129,419
+34,176
+36% +$87.1K
GOSS icon
825
Gossamer Bio
GOSS
$83.3M
$393K ﹤0.01%
45,254
-465
-1% -$4.48K
31 32
33
34 35

Similar funds

State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s Q1 2022 Portfolio in Review

As of Q1 2022, Connor, Clark & Lunn Investment Management (CC&L) held 1,305 positions worth $20.4B, down 0.39% from $20.5B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L)'s Q1 2022 filing shows 241 new, 339 increased, 426 reduced and 291 closed positions. Its largest new stake was CVS Health: 264,540 shares worth $26.8M. The largest sale was Cameco, an estimated $85.9M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Technology and Energy.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q1 2022 buy was CVS Health: 264,540 shares worth $26.8M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Enbridge in Q1 2022, an estimated $166M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q1 2022 reduction was Cameco, cutting an estimated $85.9M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Kirkland Lake Gold Ltd Ordinary in Q1 2022, selling an estimated $21.5M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 31% of its $20.4B portfolio in Q1 2022.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 241 new positions and closed 291 in Q1 2022.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value fell 0.39% quarter-over-quarter to $20.4B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2022, filed 12 May 2022.